Dialogue drives progress. By bringing together regulators, investors, and industry leaders, we create a platform where bold ideas and informed debate translate into commercial opportunity. Every conversation moves Europe’s cannabis industry closer to sustainable growth and mainstream recognition.
Through high-level discussion and networking, these events drive the dialogue that informs regulation, attracts capital, and sets the agenda for what is to come in Europe’s legal industry.
16 February 2026
26 - 27 May 2026
Attendees from 40+ Countries
Access
We are committed to improving patient access to safe and effective cannabis-based medicines, ensuring treatments reach those who need them most.
Education & Destigmatisation
We believe education is key to progress, empowering policymakers, healthcare professionals, and the public with clear, evidence-based knowledge of cannabis for medicinal use.
Innovation
We encourage research, investment, and entrepreneurship that unlock new applications of the cannabis plant and advance Europe’s cannabis economy.
Impact
We recognise cannabis as a force for positive change — enriching lives, strengthening communities, and contributing to healthier societies.
Collaboration
We bring together voices from policy, science, investment, and industry to build a responsible and sustainable cannabis sector in Europe.
Independence. We provide a platform for diverse viewpoints and build dialogue based on facts.
Responsibility. We promote practices that align with science, ethics, and the law.
Transparency. We openly discuss risks, regulations, and quality standards.
Inclusion. Equal access to knowledge and opportunities for all.
Our leadership team unites experience from both public and private sectors, both inside and outside of the cannabis industry, to drive Cannabis Europa’s mission.
We’re proud to be supported by change-enabling organisations at the forefront of cannabis innovation, investment, and policy reform.
Yes, medical cannabis was legalised in November 2018 and can be prescribed by specialist doctors on the General Medical Council’s (GMC) Specialist Register. Although it is available as a treatment on the NHS, the overwhelming majority of patients in the UK – estimated at 80,000 by Prohibition Partners – are treated by private clinics.
Medical cannabis is not yet fully legalised in France, like it is in the UK, for example, but it has been permitted as a treatment under a strict experimental program since 2021. This program allows a limited number of patients with severe conditions (like chronic pain resistant to treatment, certain forms of epilepsy, and chemotherapy-related issues) to access medical cannabis prescribed by specialists.
Cannabis Europa is a business-to-business (B2B) event, so delegates are typically senior business executives from the worlds of cannabis and beyond. Approximately 70% of our audience are C-Suite executives.
Many events still focus heavily on cannabis consumer culture and cultivation. Cannabis Europa stands out by convening policymakers, regulators, and investors at the same table as industry leaders — giving it real influence over Europe’s regulatory and commercial future. Our events drive changes in policy, commerce and capital flow.
Cannabis Europa covers the full spectrum of issues shaping Europe’s cannabis industry — from policy, regulation, and patient access to investment, research, and commercial innovation. Through high-level discussions and networking, delegates explore the opportunities and challenges driving the evolution of medical cannabis and the wider European market.
There is a cost associated with attending Cannabis Europa events, and you’ll need a ticket to gain entry. In some instances, there will be concession tickets (heavily discounted) or free passes (for media). But in the vast majority of cases, a ticket will need to be purchased to attend.
We have sponsorship and exhibitor application forms available on our website, which you can use to apply to become a sponsor or exhibitor. Alternatively, you can email info@cannabis-europa.com for more information about the sponsorship and exhibiting opportunities available at our upcoming events.
Cannabis Europa offers a range of opportunities to put your brand in front of the most influential stakeholders in Europe’s cannabis industry. From tailored sponsorship packages and high-visibility exhibition stands to thought-leadership sessions and exclusive networking events, partners can align their brand with the leading forum for cannabis policy, investment, and commerce.
We encourage potential speakers to apply to speak via our website. We’re not a pure ‘pay-to-play’ event, we have a wide variety of speakers – from scientific experts to commercial business leaders – who provide their expert insights live on stage. If you’re interested in speaking at a Cannabis Europa event, you can apply via our website and one of our friendly team will be in contact with you to discuss your application.
Yes! Although Cannabis Europa is traditionally a B2B event, we have strong links with patients and patient advocacy organisations. Thus, we generally have a number of patients in attendance at our events. Without them, our mission, values and events would cease to exist. We also offer concession tickets for patients. Apply for a concession by emailing info@cannabiseuropa.com
